[The treatment of patients with broncho-pulmonary pathology and concomitant disturbances of oxalic acid metabolism].
This work was aimed at estimating the role of special therapy of patients with bronchial asthma, COPD and hyperoxaluria designed to restrict the delivery or eliminate excess of oxalates and producing well apparent beneficial effect confirmed by the disappearance or decrease of clinical and functional manifestations of obstruction, reduction of requirements for broncholytic and anti-inflammatory agents.
L O
LO
Shaĭlieva
G B
GB
Fedoseev
M L
ML
Zorina
M A
MA
Petrova
V I
VI
Trofimov
A P
AP
Kakliugin
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D006959:Hyperoxaluria / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D019815:Oxalic Acid / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000378:metabolism / Q000628:therapy; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D019815:Oxalic Acid